Journal Home
Search for

Volume 40, Issue 7, Pages 561-564 (October 2009)


View previous. 9 of 24 View next.

Does Defective Apoptosis Play A Role in Cystic Fibrosis Lung Disease?

Ebru YalçinCorresponding Author Informationemail address, Beril Talim, Uğur Özçelik, Deniz Doğru, Nazan Çobanoğlu, Sevgi Pekcan, Nural Kiper

Received 10 November 2008; accepted 22 June 2009. published online 27 September 2009.

Background and Aims

Although apoptotic dysfunction has recently been suggested in cystic fibrosis (CF), there are few studies reported concerning apoptosis in CF with controversial results. The aim of this study was to investigate apoptosis in CF human lung tissues and compare with non-CF bronchiectatic and normal healthy lung tissues. We also investigated the relation between apoptosis and histopathological features of tissues and microbiological factors influencing apoptosis.

Methods

Lung tissue samples from CF (n=30), non-CF bronchiectasis (n=28, BE group) and normal control cases (n=24, C group) were included in the study. Histological examination of H & E-stained archived slides was performed and TUNEL method was used to detect DNA fragmentation.

Results

Apoptotic alveolar epithelial cells were significantly increased in the CF group compared to BE and C groups (p=0.046). Bronchopneumonia (BP) was present in 15 CF cases (50%), whereas none of the cases in C group had BP (p=0.0001). Apoptosis was significantly increased in cases with BP (n=17) compared to cases without BP (n=65) (p=0.04).

Conclusions

Apoptotic epithelial cells and BP were significantly increased in the CF group and excess level of apoptosis may be the result of enhanced occurrence of BP. Apoptotic cells were alveolar epithelial cells in the great majority of the patients and were not detected in other locations where CFTR expression is much more prominent than alveolar cells. We may postulate that increased apoptotic findings in the alveolar epithelium were related with the presence of chronic infections rather than CFTR dysfunction.

(ARCMED-D-08-00509)

Chest Diseases Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey

Corresponding Author InformationAddress reprint requests to: Ebru Yalçin, M.D., Pediatric Chest Diseases Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, 06100 Ankara, Turkey; Phone: (+90) 312 305 1334; FAX: (+90) 312 324 3284

PII: S0188-4409(09)00131-3

doi:10.1016/j.arcmed.2009.07.005


View previous. 9 of 24 View next.